Skip to main content

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

Q4 2025 vs. Q3 2025

How the institutions holding iTeos Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ITOS: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders10−1
Shares2320−232 (−100.0%)
Value$2.35K$0−$2.35K (−100.0%)

New holders (0)

Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

None.

Sold out (1)

Institutions that held iTeos Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of ITOS in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
IFP Advisors, Inc232$2.35K